-20℃ 3 years powder
-80℃ 2 years in solvent
Darunavir is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | 30.00 | |
2 mg | In stock | 38.00 | |
5 mg | In stock | 50.00 | |
10 mg | In stock | 60.00 | |
25 mg | In stock | 92.00 | |
50 mg | In stock | 120.00 | |
100 mg | In stock | 150.00 | |
1 mL * 10 mM (in DMSO) | In stock | 60.00 |
Description | Darunavir is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS. |
Targets&IC50 | HIV Protease, |
In vivo | Vipadenant (0.3-30 mg/kg) produces a dose-dependent reduction in catalepsy. Vipadenant (10 mg/kg) does not produce any statistically significant dyskinetic episodes in 6-OHDA-lesioned rats during a 19-day dosing regimen[1]. In the mouse and rat haloperidol-induced hypolocomotion models, vipadenant has a minimum effective dose of 0.1 and 1 mg/kg, respectively. Vipadenant (3 and 10 mg/kg, p.o.) is able to increase contralateral rotations in 6-OHDA lesioned rats[2]. |
Synonyms | TMC114 |
Purity | 99.69% |
Appearance | solid |
Molecular Weight | 547.66 |
Formula | C27H37N3O7S |
CAS No. | 206361-99-1 |
-20℃ 3 years powder
-80℃ 2 years in solvent
Ethanol: 35 mg/mL (78.14 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.